Correlation Between Shanghai Pharmaceuticals and Xinhua Winshare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shanghai Pharmaceuticals and Xinhua Winshare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Pharmaceuticals and Xinhua Winshare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Pharmaceuticals Holding and Xinhua Winshare Publishing, you can compare the effects of market volatilities on Shanghai Pharmaceuticals and Xinhua Winshare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Pharmaceuticals with a short position of Xinhua Winshare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Pharmaceuticals and Xinhua Winshare.

Diversification Opportunities for Shanghai Pharmaceuticals and Xinhua Winshare

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Shanghai and Xinhua is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Pharmaceuticals Holdi and Xinhua Winshare Publishing in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xinhua Winshare Publ and Shanghai Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Pharmaceuticals Holding are associated (or correlated) with Xinhua Winshare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xinhua Winshare Publ has no effect on the direction of Shanghai Pharmaceuticals i.e., Shanghai Pharmaceuticals and Xinhua Winshare go up and down completely randomly.

Pair Corralation between Shanghai Pharmaceuticals and Xinhua Winshare

Assuming the 90 days trading horizon Shanghai Pharmaceuticals Holding is expected to generate 0.8 times more return on investment than Xinhua Winshare. However, Shanghai Pharmaceuticals Holding is 1.25 times less risky than Xinhua Winshare. It trades about 0.08 of its potential returns per unit of risk. Xinhua Winshare Publishing is currently generating about 0.01 per unit of risk. If you would invest  1,867  in Shanghai Pharmaceuticals Holding on September 14, 2024 and sell it today you would earn a total of  307.00  from holding Shanghai Pharmaceuticals Holding or generate 16.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shanghai Pharmaceuticals Holdi  vs.  Xinhua Winshare Publishing

 Performance 
       Timeline  
Shanghai Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Pharmaceuticals Holding are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Xinhua Winshare Publ 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xinhua Winshare Publishing are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Xinhua Winshare may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Shanghai Pharmaceuticals and Xinhua Winshare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shanghai Pharmaceuticals and Xinhua Winshare

The main advantage of trading using opposite Shanghai Pharmaceuticals and Xinhua Winshare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Pharmaceuticals position performs unexpectedly, Xinhua Winshare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xinhua Winshare will offset losses from the drop in Xinhua Winshare's long position.
The idea behind Shanghai Pharmaceuticals Holding and Xinhua Winshare Publishing pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas